The effect of structural modifications on beta 93 sulfhydryl reactivity of human hemoglobin studied by means of selected mutations and minor components.
D004220:Disulfides / Q000494:pharmacology; D004228:Dithionitrobenzoic Acid / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology; D006441:Hemoglobin A / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008706:Methemoglobin / Q000378:metabolism; D009154:Mutation; D010108:Oxyhemoglobins / Q000378:metabolism; D011487:Protein Conformation; D011725:Pyridines / Q000494:pharmacology; D013438:Sulfhydryl Compounds
D004220:Disulfides; D010108:Oxyhemoglobins; D011725:Pyridines; D013438:Sulfhydryl Compounds; C004847:3,3'-dipyridyl disulfide; D008706:Methemoglobin; D006441:Hemoglobin A; D004228:Dithionitrobenzoic Acid; D005978:Glutathione